anyone knows how good is usmleconsult q bank ? - fs3

[ArchivalUser]

hi anyone has the idea how the usmleconsult q bank is ? want to know how the questions are ? similar to usmle exam or uw ?

Thanks appreciate your response

[ArchivalUser]

hi everyone
did uw twice, but weak in neonatology, obgyn and ethics. feel like know the answers and want to test with new questions after reviewing the theory again.
guys plz give inputs if anyone knows about usmleconsult q bank.

thanks.

[ArchivalUser]

It is like taking a big long trip around the world.

[ArchivalUser]

okay but how about the questions. Are they similar to uw or usmle style thats what i want to know before i subscribe.

thanks.

[ArchivalUser]

No they are not. The questions are toooooo long.
if you had done uw, then do Kaplan , then usmlerx

[ArchivalUser]

@myki.... when r u gonna take ur test?? seems like u've finished up everything

[ArchivalUser]

btw,, though expensive they are the highest yeild material thats out there,, my friend took the test,, came home and told me about 80 questions flat,, he somehow remembers and after a week I am doing this expensive consult 123 , trying to finish in 7 days so that I dont have to pay heavily again,, and belive me when I say , I found all those 80 questions with explanations and all. another good thing is you can copy paste from it and save all those high yeilds as ms notes,, no need to buy again. the ccs is crappy, will hurt your confidence a lot and not anywhere like the real thing,, so just copy paste sequences and mug it up...lol

[ArchivalUser]

i believe one can ace with just the kap qbank and the usmleconsult qbank,, with stress on the later,, uw is a waste of money particularily for step 3

[ArchivalUser]

This is a sample from usmle consult:

An 8-year-old girl is brought to her pediatrician becasue her asthma medication has "stopped working". She was first diagnosed at age 3 years following a cough that occurred 2 to 3 times per week, usually at night or in the early morning hours, and three episodes of acute bronchitis over a 12 month period. At the time physical examination and follow-up sinus films showed no signs of sinusitis. History and skin testing identified no inciting allergenic factors. Her condition has been stable since, but with one emergency department visit 2 years ago for an acute exacerbation that resolved with a short course of oral steroids. Historically 1 to 2 puffs of her albuterol inhaler 2 to 3 times per day during symptomatic episodes provided satisfactory relief. Today the child reports that there is no change in frequency of symptomatic episodes (3 to 4 times per week), but that over the past 3 months, she required increased albuterol dosages, sometimes as much as 6 puffs every 4 to 5 hours to achieve desired relief. She also complains that she experiences tremulousness of the hands and very unpleasant overall œjitteriness for several hours after these episodes. Her asthma diary shows that recent acute episodes remain associated with a historically consistent expiratory flow (PEF) between 70% to 75% of predicted value and PEF variation of 20% to 25%. During asymptomatic periods her PEF is equal to predicted values. Medication, in addition to her quick relief albuterol inhaler, is inhaled fluticasone 440 mcg/day. Vital signs are temperature 37.1 °C (98.7 °F), blood pressure (BP) 115/65 mm Hg, heart rate 58 beats/minute, respiration rate 14 breaths/minute. Physical examination is normal as has been typical on her previous every 6-month appointments since her ED visit 2 years ago. What change to the current pharmacotheraputic regimen will likely provide greatest benefit to this patient?
Question (QID: 45344) You answered this question incorrectly
An 8-year-old girl is brought to her pediatrician becasue her asthma medication has "stopped working". She was first diagnosed at age 3 years following a cough that occurred 2 to 3 times per week, usually at night or in the early morning hours, and three episodes of acute bronchitis over a 12 month period. At the time physical examination and follow-up sinus films showed no signs of sinusitis. History and skin testing identified no inciting allergenic factors. Her condition has been stable since, but with one emergency department visit 2 years ago for an acute exacerbation that resolved with a short course of oral steroids. Historically 1 to 2 puffs of her albuterol inhaler 2 to 3 times per day during symptomatic episodes provided satisfactory relief. Today the child reports that there is no change in frequency of symptomatic episodes (3 to 4 times per week), but that over the past 3 months, she required increased albuterol dosages, sometimes as much as 6 puffs every 4 to 5 hours to achieve desired relief. She also complains that she experiences tremulousness of the hands and very unpleasant overall œjitteriness for several hours after these episodes. Her asthma diary shows that recent acute episodes remain associated with a historically consistent expiratory flow (PEF) between 70% to 75% of predicted value and PEF variation of 20% to 25%. During asymptomatic periods her PEF is equal to predicted values. Medication, in addition to her quick relief albuterol inhaler, is inhaled fluticasone 440 mcg/day. Vital signs are temperature 37.1 °C (98.7 °F), blood pressure (BP) 115/65 mm Hg, heart rate 58 beats/minute, respiration rate 14 breaths/minute. Physical examination is normal as has been typical on her previous every 6-month appointments since her ED visit 2 years ago. What change to the current pharmacotheraputic regimen will likely provide greatest benefit to this patient?

Answer Choices Correct answer Your answer

A. Addition of daily montelukast to the long-term control regimen
B.
Addition of twice daily inhaled salmeterol to the long-term control regimen
C. Substitute cromolyn sodium via nebulizer for albuterol during symptomatic episodes
D.
Substitute inhaled levalbuterol via nebulizer for albuterol during symptomatic episodes
E. Trial of monthly subcutaneous omalizumab injections
Explanation
Option D (Substitute inhaled levalbuterol via nebulizer for albuterol during symptomatic episodes) is correct. The patient by definition has mild persistent asthma. Although she has not reached recommended maximal dose of albuterol for her symptomatic episodes, she is likely experiencing adverse effects of the beta-2-agonist (tremor). Levabuterol is the R isomer form of albuterol. This non-racemic preparation is effective in smaller doses and has fewer side effects compared to (racemic) albuterol.

Option A (Addition of daily montelukast to the long-term control regimen) is incorrect. Leukotriene inhibitors may be useful first line therapy for treatment of asthma in children, but this will not decrease the severity of exacerbations once they are underway. The child has not reached maximal dose of albuterol for her symptomatic episodes, but she is likely experiencing adverse effects of the beta-2-agonist (tremor). Levabuterol is the R isomer form of albuterol. This non-racemic preparation is effective in smaller doses and has fewer side effects compared to (racemic) albuterol.

Option B (Addition of twice daily inhaled salmeterol to the long-term control regimen) is incorrect. Salmeterol is a long-acting beta-2 agonist used for treatment of exercise induced and nocturnal asthma. The agent has no anti-inflammatory effects and is not effective in treatment of acute asthma episodes.

Option C (Substitute cromolyn sodium via nebulizer for albuterol during symptomatic episodes) is incorrect. Cromolyn sodium is a mast cell membrane stabilizer that inhibits acute response to cold air and exercise. They are not effective agents during acute bronchospastic episodes. Beta-2 agonists are required for treatment of acute bronchospastic episodes in patients with asthma.

Option E (Trial of monthly subcutaneous omalizumab injections) is incorrect. Omalizumab is a monoclonal IgG antibody that binds human mast cell and basophil surface IgE. The agent is indicated for moderate to severe persistent asthma in patients reactive to seasonal allergens whose symptoms are not satisfactorily controlled with inhaled steroids. Omalizumab is not effective in treatment of acute asthma.

[ArchivalUser]

thanks mykawaiigirl and doc_swarna for the inputs.
Appreciate your patience and effort in replying.

Doc_swarna
you want me to go to the usmle consult straight away or be done with kap q bank and then start usmle consult. did kap around 60 %
exam in one month
thanks for your inputs.